Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's Disease
- Conditions
- Parkinson's Disease
- Registration Number
- NCT00748488
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
Patients with Parkinson's disease (PD) are heavily inclined towards a sedentary lifestyle. This is caused by a combination of physical impairments and cognitive dysfunction. However, regular physical activity in PD is highly desirable, for two reasons. First, physical activity has positive generic effects in preventing complications such as cardiovascular diseases, type II diabetes mellitus, osteoporosis and certain cases of cancer. Secondly, physical activity has additional disease-specific merits in PD such as depression, sleep disturbances and constipation. These effects lead to raised quality of life. Furthermore, animal studies suggest that physical activity could slow down disease progression.
Simply informing patients about the importance of physical activity is not enough to initiate and maintain an adequate level of physical activity. We propose to develop a physical activity promoting program for sedentary patients with PD in order to raise their level of daily physical activity.
Objective: The first aim of the study is to investigate whether a physical activity promotion program will result in an increase in physical activity in sedentary patients with PD.
The second aim is to demonstrate an increase in physical fitness and quality of life.
- Detailed Description
no extensive description
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 700
- Idiopathic PD
- Hoehn and Yahr stage I-III
- Between 40 and 75 years old
- Not meeting the norm for healthy physical activity: the latter being defined according to international standards as either five days a week 30 minutes of moderate-intensity physical activity, or 3 days a week 20 minutes of vigorous-intensity physical activity
- Wheel chair bounded
- Severe co-morbidity (e.g. orthopaedic disorders or chronic hart failure)
- Severe cognitive decline, defined as Mini Mental State Examination < 24
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Level of Physical Activity based on the LAPAQ questionnaire Average of 6, 12, 18 and 24 months
- Secondary Outcome Measures
Name Time Method disease severity ( Nine Hole Peg test, UPDRS) 12 and 24 months Fatigue (FSS) 6, 12, 18 and 24 months Level of Physical Activity based on an activity monitor continuous during 24 months Quality of Life (PDQ-39) 6, 12, 18 and 24 months Mood and Depression (HADS) 6, 12, 18 and 24 months Safety(Falls) monthly Medication (questionnaire) 6, 12, 18 and 24 months One week diary of physical activity Average of 6, 12, 18 and 24 months Physical Fitness (Six Minute Walk Test & Astrand bicycle test) 12 and 24 months Medical Costs (questionnaire) 6, 12, 18 and 24 months Quality of Sleep (SCOPA-sleep) 6, 12, 18 and 24 months Mobility (Timed up and go test) 12 and 24 months Cognition (CANTAB) 12 and 24 months
Trial Locations
- Locations (31)
Tergooiziekenhuizen
🇳🇱Blaricum, Postbus 900, Netherlands
Jeroen Bosch Ziekenhuis
🇳🇱Den Bosch, Postbus 1101, Netherlands
Catharina ziekenhuis
🇳🇱Eindhoven, Postbus 1350, Netherlands
Vie Curie Medisch Centrum
🇳🇱Venlo, Postbus 1926, Netherlands
Hagaziekhuis
🇳🇱Den Haag, Postbus 40551, Netherlands
Medisch Centrum Haaglanden
🇳🇱Den Haag, Postbus 432, Netherlands
Medisch Centrum alkmaar
🇳🇱Alkmaar, Postbus 50, Netherlands
Maaslandziekenhuis
🇳🇱Sittard, Postbus 5500, Netherlands
Gelreziekenhuizen
🇳🇱Apeldoorn, Postbus 9014, Netherlands
Amphia Ziekenhuis
🇳🇱Breda, Postbus 90157, Netherlands
Scroll for more (21 remaining)Tergooiziekenhuizen🇳🇱Blaricum, Postbus 900, Netherlands